Clinical Trial Update: The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage

View source ↗

Summary

A completed clinical trial investigated the role of CSF tau and amyloid-β (40/42) in the pathogenesis of Terson syndrome among patients with aneurysmal subarach…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage
• Terson Syndrome

Snippet

Sponsor: Holger Joswig | Conditions: Subarachnoid Hemorrhage, Terson Syndrome | Status: COMPLETED